Abstract
The recognition that thrombolytic therapy may be beneficial for coronary thrombolysis has led to an increased use of plasminogen activators in critically ill patients, sometimes with inadequate monitoring. This review delineates the components of the fibrinolytic system, describes mechanisms of fibrinolysis, and presents practical guidelines for monitoring the use of activators of the system.
Original language | English (US) |
---|---|
Pages (from-to) | 879-886 |
Number of pages | 8 |
Journal | The American Journal of Medicine |
Volume | 76 |
Issue number | 5 |
DOIs | |
State | Published - May 1984 |
ASJC Scopus subject areas
- Medicine(all)